Skip to main content

Day: November 4, 2025

PEDEVCO Announces Closing of Transformative Merger to Become Premier Rockies Operator

HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) — PEDEVCO Corp. (NYSE American: PED), (“PEDEVCO” or the “Company”) announced today that it has merged with certain portfolio companies (the “Portfolio Companies”) controlled by Juniper Capital Advisors, L.P. (together with affiliates, “Juniper”), which own substantial oil-weighted producing assets and significant leasehold interests with future drilling inventory located in the Northern DJ and Powder River Basins (the “Transaction”). As consideration, PEDEVCO issued 10,650,000 shares of PEDEVCO Series A Convertible Preferred (the “Convertible Preferred Shares”) stock, convertible into 106,500,000 shares of common stock of the Company, and PEDEVCO has refinanced the Portfolio Companies’ previously outstanding debt and preferred equity. Simultaneously with the closing of the Transaction, PEDEVCO...

Continue reading

FLUENT Completes First Harvests at Rosa Facility, Advancing Its Growth Strategy and Proving Operational Execution

TAMPA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced the successful completion of the first series of harvests at Rosa, the company’s newest Florida indoor cultivation facility. The inaugural harvests represent another significant operational milestone as FLUENT continues to expand its premium production capacity and elevate the quality of its flower offerings in Florida. The newly operational facility, adjacent to FLUENT’S existing large-scale Tampa cultivation campus, will increase the company’s premium indoor flower canopy by approximately 25%.Rosa’s debut harvests are expected to deliver strong results, with the first yielding 400 pounds of flower, more than 70% of which consists of large and medium premium buds, as the team continues to focus...

Continue reading

Questex Strengthens its Leadership Position in the Booming $88.2 Billion Life Sciences Industry, Acquires The Conference Forum and Versalinx Global Events

Acquisitions Complement Questex’s Powerhouse Fierce Healthcare & Life Sciences Assets NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Questex, a leading authority in the healthcare and life sciences sector, today announces the acquisitions of The Conference Forum and Versalinx Global Events. The life sciences industry is booming with $88.2 billion in sales (2024) and is expected to grow to $269.56 billion by 2034, at a CAGR of 12% (Towards Healthcare). The acquisitions of The Conference Forum and Versalinx Global Events support Questex’s overarching growth strategy focused on both organic and strategic expansion within fast-evolving, high-growth industries, enhancing its powerhouse global healthcare & life sciences portfolio. By integrating specialized expertise, Questex can provide access to a larger audience and networks,...

Continue reading

Arctic Wolf Invests to Advance Aurora Endpoint Security with AI-Powered Ransomware Prevention and Rollback Capabilities

Acquisition of UpSight Security will enhance the Aurora Platform with predictive AI to strengthen protection and accelerate endpoint security outcomes EDEN PRAIRIE, Minn., Nov. 04, 2025 (GLOBE NEWSWIRE) — Arctic Wolf®, a global leader in security operations, today announced plans to enhance Aurora™ Endpoint Security with upcoming AI-powered ransomware prevention and rollback capabilities. Through the acquisition of UpSight Security, Arctic Wolf will accelerate the development and future delivery of these features, expanding its ability to protect organizations against ransomware, credential theft, and other advanced endpoint attacks. After the integration, Arctic Wolf will leverage UpSight Security’s patented technology to enhance Aurora Endpoint Security with predictive, on-device AI models that continuously analyze billions...

Continue reading

Publishing of Eimskip’s third quarter 2025 results

Eimskipafélag Íslands hf. will publish its third quarter 2025 results after market closing on Tuesday 11 November.  Investor meeting on 12 November 2025 Eimskip invites investors and market participants to a meeting where Vilhelm Thorsteinsson, CEO and Rósa Guðmundsdóttir, CFO, will present the results. The meeting will be held on Wednesday 12 November at 8:30 GMT at the Company’s headquarters, Sundabakki 2, second floor. The meeting will also be webcasted live in Icelandic on www.eimskip.com/investors. Investors can send questions before the meeting to the email investors@eimskip.com. Documents and a recording of the meeting will be available at the Company’s investor relations website, www.eimskip.is/investors. For further information please contact Guðbjörg Birna Björnsdóttir, Head of Treasury and Investor Relations, tel: +354 844 4752,...

Continue reading

Bpce: Groupe BPCE is positioned well above the prudential capital requirements applicable in 2026 as laid down by the European Central Bank

Groupe BPCE is positioned well above the prudential capital requirements applicable in 2026 as laid down by the European Central Bank Paris, November 4, 2025 Groupe BPCE has received notification from the European Central Bank concerning the results of the Supervisory Review and Evaluation Process (SREP) conducted in 2025, stating the level of prudential capital requirements for 2025. The Common Equity Tier 1 (CET1) requirement applicable to Groupe BPCE on a consolidated basis is unchanged at 10.59% as of January 1st, 2026, including:• 1.69% with respect to the Pillar 2 requirement or P2R,• 2.5% with respect to the capital conservation buffer,• 1.0% with respect to the capital buffer for global systemically important banks (G-SIBs), • 0.90% with respect to the countercyclical buffers. The Total Capital requirement is also unchanged at...

Continue reading

Datavault AI Inc. Announces a $10M Worldwide Exclusive License Agreement with Scilex Holding Company for Tokenization and Monetization of Real-World Assets (RWA) in Genomic, DNA Data, Diagnostics, Therapeutics, Genetic, and Drug Information

PHILADELPHIA, Nov. 04, 2025 (GLOBE NEWSWIRE) — via IBN — Datavault AI Inc. (“Datavault AI” or the “Company”) (Nasdaq: DVLT), a leader in AI-driven blockchain solutions focusing on data monetization, asset tokenization, and secure digital marketplaces, today announced that it has granted a worldwide exclusive license, with the right to sublicense, to Scilex Holding Company (Nasdaq: SCLX), for Datavault AI’s proprietary AI-driven technology. This license is tailored for use within the biotech and biopharma industry, enabling Scilex to create and operate a Biotech Exchange platform. By leveraging Datavault AI’s advanced data platforms, Scilex can facilitate secure tokenization, trading, and monetization of biotech assets, including genomic and DNA data, diagnostic and therapeutic products, genetic information, and drug...

Continue reading

50/2025・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities

Schindellegi, Switzerland – 4 November 2025 Trifork Group AGCompany announcement no. 50/2025European Regulatory News Reporting of transactions made by persons discharging managerial responsibilities Pursuant to the Market Abuse Regulation Article 19, Trifork Group AG (Swiss company registration number CHE-474.101.854) (“Trifork”) hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in Trifork or persons closely associated with them.1. Details of the person discharging managerial responsibilities/person closely associateda) Name Kristian Wulf-Andersen2. Reason for the notificationa) Position/status CFOb) Initial notification/Amendment Initial notification3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or...

Continue reading

Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference

CINCINNATI, Ohio, Nov. 04, 2025 (GLOBE NEWSWIRE) — Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the UBS 2025 Global Healthcare Conference on Tuesday, November 11, 2025, at approximately 2:00 p.m. (ET) at the PGA National Resort in Palm Beach Gardens, Florida. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation’s largest provider of end-of-life hospice care...

Continue reading

Bald Hill Antimony Project Under Option From Globex Indicates Potential for 2.7 M Tonnes at 3% to 4% Sb

TORONTO, Nov. 04, 2025 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to inform shareholders that Antimony Resources Corp. (ATMY-CSE, K8JO-FSE) have reported that they have filed a NI 43-101 Technical Report on the Bald Hill Antimony Project in New Brunswick, Canada on SEDAR Plus. Globex reported the option of the Bald Hill antimony/gold property to Antimony Resources Corp. (formerly Big Red) on January 22, 2025). The document describes the project in detail, including summaries of past work, summarizes the Phase One Drilling Program completed by Antimony Resources Corp. and indicates that the project...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.